Melatobel® Granules for Pediatric Use 0.2%
Pediatric Sleep Disorders
CommercialMarketed in Japan and China
Key Facts
Indication
Pediatric Sleep Disorders
Phase
Commercial
Status
Marketed in Japan and China
Company
About Nobelpharma
Japanese pharmaceutical company developing critical but neglected drugs and medical devices for rare diseases and pediatric conditions.
View full company profileTherapeutic Areas
Other Pediatric Sleep Disorders Drugs
| Drug | Company | Phase |
|---|---|---|
| Melatobel Tablet 1 mg/2 mg | Nobelpharma | Commercial |